Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Equillium (EQ) EBT (2022 - 2025)

Equillium (EQ) has disclosed EBT for 4 consecutive years, with -$4.3 million as the latest value for Q3 2025.

  • On a quarterly basis, EBT fell 61885.71% to -$4.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$24.6 million, a 434.36% decrease, with the full-year FY2024 number at -$7.7 million, up 39.58% from a year prior.
  • EBT was -$4.3 million for Q3 2025 at Equillium, up from -$6.1 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $63.2 million in Q4 2022 to a low of -$37.4 million in Q1 2022.
  • A 4-year average of -$2.8 million and a median of -$3.9 million in 2023 define the central range for EBT.
  • Peak YoY movement for EBT: soared 114.03% in 2024, then crashed 61885.71% in 2025.
  • Equillium's EBT stood at $63.2 million in 2022, then plummeted by 103.68% to -$2.3 million in 2023, then plummeted by 133.58% to -$5.4 million in 2024, then grew by 20.14% to -$4.3 million in 2025.
  • Per Business Quant, the three most recent readings for EQ's EBT are -$4.3 million (Q3 2025), -$6.1 million (Q2 2025), and -$8.7 million (Q1 2025).